Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of mycobacterium tuberculosis in a THP1 infection model

Journal of Biomolecular Screening

Volumn 17, Issue 7, 2012, Pages 966-973

  Sarkar, Sampa ^a   Sarkar, Dhiman ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

high throughput screening; inhibitor; Mycobacterium tuberculosis; nitrate reductase; THP1

Indexed keywords

BIOLOGICAL MARKER; ETHAMBUTOL; ISONIAZID; NITRATE; NITRATE REDUCTASE; PENTACHLOROPHENOL; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; DRUG DISCOVERY; ETHAMBUTOL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; ISONIAZID; LEUKEMIA, MONOCYTIC, ACUTE; MACROPHAGES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE; PENTACHLOROPHENOL; PYRAZINAMIDE; RIFAMPIN; STREPTOMYCIN;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

EID: 84863856448     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112445485     Document Type: Article

References (35)

1. Falcone V., Collins F.. Growth of recombinant Mycobacterium tuberculosis H37Ra in mouse macrophages. Clin. Exp. Immunol. 1997 ; 109: 80-83 (Pubitemid 27293887)
2. Geiman D. E., Kaushal D., Ko C., Tyagi S., Manabe Y. C., Schroeder B. G., Fleischmann R. D., Morrison N. E., Converse P. J., Chen P., Bishai W. R.. Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the sigF alternate sigma factor and identification of sigF-dependent genes by microarray analysis. Infect. Immun. 2004: 1733-1745
3. Global Tuberculosis Control. WHO Report 2000. Geneva, Switzerland: WHO/CDS/TB/2000.27 ;
4. Parrish N. M., Dick J. D., Bishai W. R.. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998 ; 6 (3). 107-112 (Pubitemid 28123330)
5. Adams K. N., Takaki K., Connolly L. E., Wiedenhoft H., Winglee K., Humbert O., Edelstein P. H., Cosma C. L., Ramakrishnan L.. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 2011 ; 145: 1-15
6. Robinson M. A., Baumgardner J. E., Good V. P., Otto C. M.. Physiological and hypoxic O2 tensions rapidly regulate NO production by stimulated macrophages. Am. J. Physiol. Cell. Physiol. 2008 ; 294: C1079 - C1087
7. James P. E., Grinberg O. Y., Michaels G., Swartz H. M.. Intraphagosomal oxygen in stimulated macrophages. J. Cell Physiol. 1995 ; 163: 241-247
8. Dev C., Lee C.-M., Dubey V. S., Daniel J., Abomoelak B., Sirakova T. D., Pawar S., Rogers L., Kolattukudy P. E.. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLos ONE. 2009 ; 4: e6077
9. Nyka W.. Studies on the effect of starvation on Mycobacteria. Infect. Immun. 1973: 843-850
10. Wayne L. G., Sohaskey C. D.. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 2001 ; 55: 139-163 (Pubitemid 32978103)
11. Wayne L. G., Hayes L. G.. Nitrate reduction as a marker for hypoxic shift down of Mycobacterium tuberculosis. Tuber. Lung Dis. 1998 ; 79: 127-32 (Pubitemid 29078282)
12. Khan A., Sarkar D.. A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli. J. Microbiol. Methods. 2008 ; 73: 62-68
13. Arain T. M., Resconi A. E., Hickey M. J., Stover C. K.. Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob. Agents Chemother. 1996 ; 40: 1536-1541 (Pubitemid 26169064)
14. Kharatmal S., Jhamb S. S., Singh P. P.. Evaluation of BACTEC 460 TB system for rapid in vitro screening of drugs against latent state Mycobacterium tuberculosis H37Rv under hypoxia conditions. J. Microbiol. Methods. 2009 ; 78: 161-164
15. Takemasa T., Yoshifumi Y., Taku C., Chiyoji A., John T. B., Patrick J. B., Kikuo O.. Simple fibroblast-based assay for screening of new antimicrobial drugs against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002 ; 46: 2533-2539
16. Arain T. M., Resconi A. E., Singh D. C., Stover C. K.. Reporter gene technology to assess activity of antimycobacterial agents in macrophage Antimicrob. Agents Chemother. 1996 ; 40: 1542-1544 (Pubitemid 26169065)
17. Reddy M. V., Srinivasan S., Andersen B., Gangadharam P. R.. Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method. Tuber Lung Dis. 1994 ; 75: 127-131 (Pubitemid 24157899)
18. Zhang J.-H., Chung T. D. Y., Oldenburg K. R.. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999 ; 4: 67-73 (Pubitemid 29278954)
19. Rastogi N., Labrousse V., Goh K. S.. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol. 1996 ; 33: 167-175 (Pubitemid 26272372)
20. Srivastava R., Deb D. K., Srivastava K. K., Locht C., Srivastava B. S.. Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages. Biochem. Biophys. Res. Commun. 1998 ; 253: 431-436 (Pubitemid 29026719)
21. Blanchard J. S.. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu. Rev. 1996 ; 65: 215-239 (Pubitemid 26250609)
22. Carrière C., Riska P. F., Zimhony O., Kriakov J., Bardarov S., Burns J., Chan J. J., Jacobs W. R.. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 1997 ; 35: 3232-3239 (Pubitemid 27505750)
23. Hickey M. J., Arain T. M., Shawar R. M., Humble D. J., Langhorne M. H., Morgenroth J. N., Stover C. K.. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 1996 ; 4: 400-407 (Pubitemid 26053139)
24. Riska P. F., Su Y., Bardarov S., Freundlich L., Sarkis G., Hatfull G., Carriere C., Kumar V., Chan J., Jacobs W. R.. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J. Clin. Microbiol. 1999 ; 37: 1144-1149 (Pubitemid 29140627)
25. Zafer A. A., Taylor Y. E., Sattar S. A.. Rapid screening method for mycobactericidal activity of chemical germicides that uses Mycobacterium terrae expressing a green fluorescent protein gene. Appl. Environ. Microbiol. 2001 ; 67: 1239-1245 (Pubitemid 33643566)
26. Khan A., Sarkar S., Sarkar D.. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. Int. J. Antimicrob. Agents. 2008 ; 32: 40-45
27. Nicholas D. J. D., Nason A.. Determination of nitrate and nitrite. Meth. Enzymol. 1957 ; 3: 981-984
28. Bapela N. B., Lall N., Fourie P. B., Franzblau S. G., Van Rensburg C. E. J.. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine. 2006 ; 13: 9-10
29. Taraq M. A., Anna E. R., Devinder C. S., Kendall C. S.. Reporter gene technology to assess activity of antimycobacterial agents in macrophages 1996. Antimicrob. Agents Chemother 40.: 1542-1544
30. Indra L. B., Anja R. J. S., Paul R. K., Richard M. A.. Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. J. Antimicrob. Chemother. 2009 ; 64: 515-523
31. Devyani D., Shashikant S., Claudia M., Richard L., Tawanda G.. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium. Antimicrob. Agents Chemother. 2010 ; 54: 1728-1733
32. Sohaskey C. D., Modesti L.. Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2. FEMS Microbiol. Lett. 2009 ; 290: 129-134
33. Khan A., Sarkar D.. Identification of a respiratory-type nitrate reductase and its role for survival of Mycobacterium smegmatis in Wayne model. Microb Pathog. 2006 ; 42: 90-95 (Pubitemid 44223946)
34. Metchock B. G., Nolte F. S., Wallace R. J.. Mycobacterium. MCM. 1999: 399-437
35. Boon C., Dick T.. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J. Bacteriol. 2002 ; 184: 6760-6767 (Pubitemid 36356110)